대장 표적 약물전달 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 8.3%의 연평균 성장률로 20억 7,000만 달러에 달할 것으로 예상됩니다. 이 예측 기간 동안의 성장은 자극 반응성 및 나노기술 기반 전달 시스템 개발, 위탁 R&D 및 제조 서비스 확대, 규제 당국의 인센티브 제공 및 승인 경로 가속화, 생물학적 제제 및 바이오시밀러의 표적 전달에 기인할 것으로 보입니다. 이 기간 동안 주요 동향으로는 pH 반응성 시스템의 발전, 맞춤형 의료의 통합, 제제 설계에 AI 및 디지털 툴의 활용, 경구용 대장 전달에 대한 관심 증가 등을 들 수 있습니다.
소화기 질환의 유병률 증가는 대장 표적 약물전달 시장의 성장을 촉진할 것으로 예상됩니다. 위, 장 및 관련 장기를 포함한 소화기 계통에 영향을 미치는 위장 질환은 가공식품의 과다 섭취와 낮은 식이섬유 섭취와 같은 건강에 해로운 식습관으로 인해 점점 더 흔해지고 있습니다. 이러한 식습관은 장 건강과 소화를 방해하고 염증성 장질환(IBD)과 같은 질환의 증가로 이어집니다. 대장 표적 약물전달은 약물이 염증 및 감염 부위에 정확하게 방출되어 치료 효과를 높이고 전신 부작용을 최소화하기 위해 사용되고 있습니다. 예를 들어, 2023년 6월 Crohn's and Colitis Canada는 염증성 장질환 환자 수가 2023년 32만 2,600명(인구의 0.8%)에서 2035년 47만 명(인구의 1.1%)으로 증가할 것으로 예측하고 있습니다. 이러한 소화기 질환의 유병률 증가가 대장 표적 약물전달 솔루션에 대한 수요를 촉진하고 있습니다.
대장 표적 약물전달 시장의 기업들은 표적 약물의 방출을 개선하고, 치료 효과를 높이고, 부작용을 줄이기 위한 첨단 솔루션 개발에 주력하고 있습니다. 이러한 혁신 중 하나는 기능성 경구용 제형의 개발로, 상부 소화관에서의 분해로부터 활성 제약 성분(API)을 보호하고 대장에서의 방출 제어를 보장하도록 설계된 기능성 경구용 제형의 개발입니다. 2024년 9월, 독일의 특수화학 제조업체인 Evonik Industries AG는 대장에 경구 약물전달을 가능하게 하는 즉시 충전 가능한 캡슐 기술인 EUDRACAP Functional을 발표했습니다. EUDRACAP Functional은 특정 장내 pH 수준에서만 용해되는 pH 민감성 폴리머를 사용하여 약물이 그대로 대장에 도달할 수 있도록 보장하며, 펩타이드 및 프로바이오틱스와 같은 복잡한 약물의 경구 전달을 지원함으로써 만성 소화기 질환에 대한 환자 친화적인 치료법 개발을 지원하여 보다 높은 정확도와 전신 노출 감소를 실현합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 대장 표적 약물전달 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 대장 표적 약물전달 시장 : 성장률 분석
- 세계의 대장 표적 약물전달 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 대장 표적 약물전달 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 대장 표적 약물전달 전체 시장(TAM)
제6장 시장 세분화
- 세계의 대장 표적 약물전달 시장 : 제형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 정제
- 캡슐
- 마이크로스피어
- 나노입자
- 기타
- 세계의 대장 표적 약물전달 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- pH 민감성 시스템
- 시간 제어 시스템
- 미생물 유도 시스템
- 압력 제어 시스템
- 기타
- 세계의 대장 표적 약물전달 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 염증성 장질환
- 대장암
- 감염증
- 기타
- 세계의 대장 표적 약물전달 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원
- 클리닉
- 연구기관
- 기타
- 세계의 대장 표적 약물전달 시장 : 정제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 서방정
- 장용정
- 삼투압 펌프정
- 세계의 대장 표적 약물전달 시장 : 캡슐 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 하드 젤라틴 캡슐
- 소프트 젤라틴 캡슐
- 장용성 캡슐
- 세계의 대장 표적 약물전달 시장 : 마이크로스피어 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 폴리머 마이크로스피어
- 생분해성 마이크로스피어
- 비생분해성 마이크로스피어
- 세계의 대장 표적 약물전달 시장 : 나노입자 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 폴리머 나노입자
- 고체 지질 나노입자
- 덴드리머
- 지질 폴리머 하이브리드 나노입자
- 세계의 대장 표적 약물전달 시장 : 기타 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 필름
- 주사
- 하이드로겔
- 좌약
제7장 지역별·국가별 분석
- 세계의 대장 표적 약물전달 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 대장 표적 약물전달 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 대장 표적 약물전달 시장 : 경쟁 구도
- 대장 표적 약물전달 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- AstraZeneca plc
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Evonik Industries AG
- Teva Pharmaceutical Industries Ltd.
- Baxter International Inc.
- Lonza Pharma AG
- Ferring Pharmaceuticals Company Limited
- Salix Pharmaceuticals Ltd.
- Tillotts Pharma AG
- BDD Pharma Ltd.
- Tharimmune Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 대장 표적 약물전달 시장 2029년 : 새로운 기회를 제공하는 국가
- 대장 표적 약물전달 시장 2029년 : 새로운 기회를 제공하는 부문
- 대장 표적 약물전달 시장 2029년 : 성장 전략
제36장 부록
ksm
Colon targeting drug delivery refers to a specialized system designed to release therapeutic agents directly in the colon, enhancing treatment effectiveness for local diseases such as inflammatory bowel disease and colorectal cancer. This approach minimizes systemic side effects and improves patient compliance.
The main dosage forms for colon-targeted drug delivery include tablets, capsules, microspheres, nanoparticles, and others. Tablets are solid, compressed forms of medication intended for oral intake. In colon-targeted delivery, these tablets are often coated with materials that prevent dissolution in the stomach or small intestine, ensuring the drug is released specifically in the colon. Various technologies are used in these systems, including pH-sensitive systems, time-dependent systems, microbially triggered systems, pressure-controlled systems, and others. These systems are applied in treating conditions such as inflammatory bowel disease, colorectal cancer, infectious diseases, and more. They are primarily utilized by end users such as hospitals, clinics, research institutes, and other healthcare settings.
The colon targeted drug delivery market research report is one of a series of new reports from The Business Research Company that provides colon targeted drug delivery market statistics, including the colon targeted drug delivery industry's global market size, regional shares, competitors with a colon targeted drug delivery market share, detailed colon targeted drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the colon targeted drug delivery industry. This colon targeted drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The colon targeting drug delivery market size has grown strongly in recent years. It will grow from$1.39 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the rising prevalence of colorectal diseases, an increased focus on localized drug delivery, the need for improved patient compliance, and the emergence of biologics and peptides in treatment options.
The colon targeting drug delivery market size is expected to see strong growth in the next few years. It will grow to$2.07 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the development of stimuli-responsive and nanotechnology-based delivery systems, the expansion of contract research and manufacturing services, regulatory agencies providing incentives and faster approval pathways, and the targeted delivery of biologics and biosimilars. Key trends during this period include advancements in pH-responsive systems, the integration of personalized medicine, the use of AI and digital tools in formulation design, and an increasing focus on oral colon delivery.
The increasing prevalence of gastrointestinal diseases is expected to drive the expansion of the colon targeting drug delivery market. Gastrointestinal diseases, which affect the digestive system including the stomach, intestines, and related organs, are becoming more common due to unhealthy dietary habits, such as high consumption of processed foods and low fiber intake. These habits disrupt gut health and digestion, leading to a rise in conditions such as inflammatory bowel disease (IBD). Colon targeting drug delivery is being used to ensure that drugs are precisely released at the site of inflammation or infection, increasing therapeutic effectiveness and minimizing systemic side effects. For example, in June 2023, Crohn's and Colitis Canada reported that the number of people affected by inflammatory bowel disease is projected to rise from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). This growing prevalence of gastrointestinal diseases is driving demand for colon-targeting drug delivery solutions.
Companies in the colon targeting drug delivery market are focusing on developing advanced solutions that improve targeted drug release, enhance therapeutic efficacy, and reduce side effects. One such innovation is the development of functional oral dosage forms, which are designed to protect active pharmaceutical ingredients (APIs) from degradation in the upper gastrointestinal tract, ensuring their controlled release in the colon. In September 2024, Evonik Industries AG, a Germany-based specialty chemicals company, launched EUDRACAP Functional, a ready-to-fill capsule technology that enables the precise delivery of oral drugs to the colon. This technology uses pH-sensitive polymers that dissolve only at specific intestinal pH levels, ensuring that the API reaches the colon intact. By supporting the oral delivery of complex APIs such as peptides and probiotics, EUDRACAP Functional helps develop patient-friendly therapies for chronic gastrointestinal disorders, offering greater accuracy and reduced systemic exposure.
In October 2023, Roche Holding AG, a Switzerland-based healthcare company, acquired Telavant Holding Inc. for $7.1 billion. This acquisition strengthens Roche's position in the colon targeting drug delivery market by integrating Telavant's RVT-3101, a drug aimed at treating inflammatory bowel diseases. Telavant Holding Inc., a US-based biopharmaceutical company, specializes in developing therapies for gastrointestinal disorders. This strategic acquisition enhances Roche's ability to provide innovative treatments for gastrointestinal diseases, further advancing their portfolio in the field of colon-targeting drug delivery.
Major players in the colon targeting drug delivery market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Lonza Pharma AG, Ferring Pharmaceuticals Company Limited, Salix Pharmaceuticals Ltd., Tillotts Pharma AG, BDD Pharma Ltd., and Tharimmune Inc.
North America was the largest region in the colon targeting drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in colon targeting drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the colon targeting drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The colon targeting drug delivery market includes revenues earned by entities by providing services such as formulation development, preformulation studies, drug delivery technology licensing, coating and encapsulation services, and in-vitro release testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Colon Targeting Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on colon targeting drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for colon targeting drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colon targeting drug delivery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Dosage Form: Tablets; Capsules; Microspheres; Nanoparticles; Other Dosage Form
- 2) By Technology: pH-Sensitive Systems; Time-Dependent Systems; Microbially Triggered Systems; Pressure-Controlled Systems; Other Technologies
- 3) By Application: Inflammatory Bowel Disease; Colorectal Cancer; Infectious Diseases; Other Application
- 4) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
- Subsegments:
- 1) By Tablets: Extended-Release Tablets; Enteric-Coated Tablets; Osmotic Pump Tablets
- 2) By Capsules: Hard Gelatin Capsules; Soft Gelatin Capsules; Enteric-Coated Capsules
- 3) By Microspheres: Polymeric Microspheres; Biodegradable Microspheres; Non-biodegradable Microspheres
- 4) By Nanoparticles: Polymeric Nanoparticles, Solid Lipid Nanoparticles, Dendrimers, Lipid-Polymer Hybrid Nanoparticles
- 4) By Other Dosage Form: Films; Injections; Hydrogels; Suppositories
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Colon Targeting Drug Delivery Market Characteristics
3. Colon Targeting Drug Delivery Market Trends And Strategies
4. Colon Targeting Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Colon Targeting Drug Delivery Growth Analysis And Strategic Analysis Framework
- 5.1. Global Colon Targeting Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Colon Targeting Drug Delivery Market Growth Rate Analysis
- 5.4. Global Colon Targeting Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Colon Targeting Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Colon Targeting Drug Delivery Total Addressable Market (TAM)
6. Colon Targeting Drug Delivery Market Segmentation
- 6.1. Global Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Capsules
- Microspheres
- Nanoparticles
- Other Dosage Form
- 6.2. Global Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- pH-Sensitive Systems
- Time-Dependent Systems
- Microbially Triggered Systems
- Pressure-Controlled Systems
- Other Technologies
- 6.3. Global Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inflammatory Bowel Disease
- Colorectal Cancer
- Infectious Diseases
- Other Application
- 6.4. Global Colon Targeting Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Research Institutes
- Other End-Users
- 6.5. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Extended-Release Tablets
- Enteric-Coated Tablets
- Osmotic Pump Tablets
- 6.6. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hard Gelatin Capsules
- Soft Gelatin Capsules
- Enteric-Coated Capsules
- 6.7. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymeric Microspheres
- Biodegradable Microspheres
- Non-biodegradable Microspheres
- 6.8. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymeric Nanoparticles
- Solid Lipid Nanoparticles
- Dendrimers
- Lipid-Polymer Hybrid Nanoparticles
- 6.9. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Other Dosage Form, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Films
- Injections
- Hydrogels
- Suppositories
7. Colon Targeting Drug Delivery Market Regional And Country Analysis
- 7.1. Global Colon Targeting Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Colon Targeting Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Colon Targeting Drug Delivery Market
- 8.1. Asia-Pacific Colon Targeting Drug Delivery Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Colon Targeting Drug Delivery Market
- 9.1. China Colon Targeting Drug Delivery Market Overview
- 9.2. China Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Colon Targeting Drug Delivery Market
- 10.1. India Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Colon Targeting Drug Delivery Market
- 11.1. Japan Colon Targeting Drug Delivery Market Overview
- 11.2. Japan Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Colon Targeting Drug Delivery Market
- 12.1. Australia Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Colon Targeting Drug Delivery Market
- 13.1. Indonesia Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Colon Targeting Drug Delivery Market
- 14.1. South Korea Colon Targeting Drug Delivery Market Overview
- 14.2. South Korea Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Colon Targeting Drug Delivery Market
- 15.1. Western Europe Colon Targeting Drug Delivery Market Overview
- 15.2. Western Europe Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Colon Targeting Drug Delivery Market
- 16.1. UK Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Colon Targeting Drug Delivery Market
- 17.1. Germany Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Colon Targeting Drug Delivery Market
- 18.1. France Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Colon Targeting Drug Delivery Market
- 19.1. Italy Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Colon Targeting Drug Delivery Market
- 20.1. Spain Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Colon Targeting Drug Delivery Market
- 21.1. Eastern Europe Colon Targeting Drug Delivery Market Overview
- 21.2. Eastern Europe Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Colon Targeting Drug Delivery Market
- 22.1. Russia Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Colon Targeting Drug Delivery Market
- 23.1. North America Colon Targeting Drug Delivery Market Overview
- 23.2. North America Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Colon Targeting Drug Delivery Market
- 24.1. USA Colon Targeting Drug Delivery Market Overview
- 24.2. USA Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Colon Targeting Drug Delivery Market
- 25.1. Canada Colon Targeting Drug Delivery Market Overview
- 25.2. Canada Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Colon Targeting Drug Delivery Market
- 26.1. South America Colon Targeting Drug Delivery Market Overview
- 26.2. South America Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Colon Targeting Drug Delivery Market
- 27.1. Brazil Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Colon Targeting Drug Delivery Market
- 28.1. Middle East Colon Targeting Drug Delivery Market Overview
- 28.2. Middle East Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Colon Targeting Drug Delivery Market
- 29.1. Africa Colon Targeting Drug Delivery Market Overview
- 29.2. Africa Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Colon Targeting Drug Delivery Market Competitive Landscape And Company Profiles
- 30.1. Colon Targeting Drug Delivery Market Competitive Landscape
- 30.2. Colon Targeting Drug Delivery Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Colon Targeting Drug Delivery Market Other Major And Innovative Companies
- 31.1. AstraZeneca plc
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc
- 31.4. Takeda Pharmaceutical Company Limited
- 31.5. Eli Lilly and Company
- 31.6. Amgen Inc.
- 31.7. Evonik Industries AG
- 31.8. Teva Pharmaceutical Industries Ltd.
- 31.9. Baxter International Inc.
- 31.10. Lonza Pharma AG
- 31.11. Ferring Pharmaceuticals Company Limited
- 31.12. Salix Pharmaceuticals Ltd.
- 31.13. Tillotts Pharma AG
- 31.14. BDD Pharma Ltd.
- 31.15. Tharimmune Inc.
32. Global Colon Targeting Drug Delivery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Colon Targeting Drug Delivery Market
34. Recent Developments In The Colon Targeting Drug Delivery Market
35. Colon Targeting Drug Delivery Market High Potential Countries, Segments and Strategies
- 35.1 Colon Targeting Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Colon Targeting Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Colon Targeting Drug Delivery Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
